Highlights

  • Tim Hughes is set to join Iofina’s board starting 1 January 2026.
  • He will also serve on the company’s Audit and Remuneration Committees.
  • Hughes brings extensive experience in specialty chemicals and corporate development.

Iofina plc (LSE:IOF), a UK-based company engaged in the exploration and production of iodine and manufacturing of specialty chemical products, announced the proposed appointment of Tim Hughes as a Non-Executive Director, effective 1 January 2026.

Experienced Leadership in Specialty Chemicals
Tim Hughes brings over three decades of experience in the specialty chemical sector. He served for 11 years on the Executive Committee of Synthomer plc, where he was divisional director for the industrial specialties global business, including Synthomer’s specialty iodine operations. Hughes later became President of Corporate Development, overseeing investor relations, external affairs, and sustainability strategy.

Prior to Synthomer, Hughes led the Urethane Technologies joint venture for Chemtura Corporation and spent 14 years in business leadership and marketing roles at Courtaulds plc. He holds a BSc in Chemistry from the University of Manchester and an MBA from Cranfield University and is based in the UK.

Committee Assignments
Alongside his Non-Executive Director role, Hughes will join Iofina’s Audit and Remuneration Committees, providing oversight on financial reporting, compliance, and remuneration governance.

Corporate Focus and Expertise
Hughes’ appointment strengthens the board’s expertise in both the iodine sector and broader corporate management. His prior experience in investor relations, sustainability strategy, and global business management is expected to support the company’s operational and strategic oversight.

Share Price Snapshot
IOF was trading at GBX 24.00 per share as of 12 December 2025.